1. Tumor Lysis Syndrome in Patients with Hematological Malignancies
   Yohannes Belay et al, 2017, Journal of Oncology CrossRef
2. Improving cell reinfusion to enhance the efficacy of chimeric antigen receptor T-cell therapy and alleviate complications
   Zhihao Han et al, 2024, Heliyon CrossRef
3. Water‐Promoted Synthesis of Pyrazole‐Thiazole‐Derivatives as Potent Antioxidants And their Anti‐cancer Activity: ADMET and SAR Studies
   Kanji D. Kachhot et al, 2024, ChemistrySelect CrossRef
4. Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency
   M. Criscuolo et al, 2016, Expert Review of Hematology CrossRef
5. Analyse des recommandations britanniques 2015 sur la prévention et la prise en charge du syndrome de lyse tumorale
   A. Dupré et al, 2017, La Revue de Médecine Interne CrossRef
6. Drug Repurposing Patent Applications April–June 2019
   Hermann A.M. Mucke, 2020, ASSAY and Drug Development Technologies CrossRef
7. Febuxostat administration for the prevention of tumour lysis syndrome: A meta‐analysis
   Ioannis Bellos et al, 2019, Journal of Clinical Pharmacy and Therapeutics CrossRef
8. The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2
   Yoshiki Higa et al, 2023, Antioxidants CrossRef
9. The Encapsulation of Febuxostat into Emulsomes Strongly Enhances the Cytotoxic Potential of the Drug on HCT 116 Colon Cancer Cells
   Usama A. Fahmy et al, 2020, Pharmaceutics CrossRef
10. Analysis of Short-Term Clinical Efficacy of Febuxostat in the Treatment of Malignant Tumor Complicated with Hyperuricemia
    哲 黄, 2021, Advances in Clinical Medicine CrossRef
11. Purine versus non-purine xanthine oxidase inhibitors against cyclophosphamide-induced cardiac and bone marrow toxicity in rats
    AA El-Sheikh et al, 2020, Human & Experimental Toxicology CrossRef
12. The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat
    Mohannad Ashtar et al, 2020, Cancers CrossRef
13. Pharmacogenomics in Asian Subpopulations and Impacts on Commonly Prescribed Medications
    Cody Lo et al, 2020, Clinical and Translational Science CrossRef
14. Prosthetic gene networks as an alternative to standard pharmacotherapies for metabolic disorders
    Boon Chin Heng et al, 2015, Current Opinion in Biotechnology CrossRef